JP2007502608A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502608A5
JP2007502608A5 JP2006523593A JP2006523593A JP2007502608A5 JP 2007502608 A5 JP2007502608 A5 JP 2007502608A5 JP 2006523593 A JP2006523593 A JP 2006523593A JP 2006523593 A JP2006523593 A JP 2006523593A JP 2007502608 A5 JP2007502608 A5 JP 2007502608A5
Authority
JP
Japan
Prior art keywords
cells
cell
mammalian
feeder
free conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006523593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502608A6 (ja
JP2007502608A (ja
JP5129959B2 (ja
Filing date
Publication date
Priority claimed from DE10338531A external-priority patent/DE10338531A1/de
Application filed filed Critical
Publication of JP2007502608A publication Critical patent/JP2007502608A/ja
Publication of JP2007502608A6 publication Critical patent/JP2007502608A6/ja
Publication of JP2007502608A5 publication Critical patent/JP2007502608A5/ja
Application granted granted Critical
Publication of JP5129959B2 publication Critical patent/JP5129959B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006523593A 2003-08-19 2004-08-17 生産細胞の再クローン化方法 Expired - Fee Related JP5129959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10338531.2 2003-08-19
DE10338531A DE10338531A1 (de) 2003-08-19 2003-08-19 Verfahren zur Reklonierung von Produktionszellen
PCT/EP2004/009204 WO2005019442A2 (de) 2003-08-19 2004-08-17 Verfahren zur reklonierung von produktionszellen

Publications (4)

Publication Number Publication Date
JP2007502608A JP2007502608A (ja) 2007-02-15
JP2007502608A6 JP2007502608A6 (ja) 2007-05-10
JP2007502608A5 true JP2007502608A5 (cg-RX-API-DMAC7.html) 2007-10-04
JP5129959B2 JP5129959B2 (ja) 2013-01-30

Family

ID=34201814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523593A Expired - Fee Related JP5129959B2 (ja) 2003-08-19 2004-08-17 生産細胞の再クローン化方法

Country Status (11)

Country Link
US (1) US7833787B2 (cg-RX-API-DMAC7.html)
EP (2) EP1658365B1 (cg-RX-API-DMAC7.html)
JP (1) JP5129959B2 (cg-RX-API-DMAC7.html)
KR (1) KR101184572B1 (cg-RX-API-DMAC7.html)
AT (2) ATE515565T1 (cg-RX-API-DMAC7.html)
CA (1) CA2536239C (cg-RX-API-DMAC7.html)
DE (2) DE10338531A1 (cg-RX-API-DMAC7.html)
DK (2) DK1658365T3 (cg-RX-API-DMAC7.html)
ES (2) ES2317023T3 (cg-RX-API-DMAC7.html)
TW (1) TWI337201B (cg-RX-API-DMAC7.html)
WO (1) WO2005019442A2 (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060223183A1 (en) * 2005-03-11 2006-10-05 Bates Steven E Gamma irradiation of frozen feeder cells
EP1901068A1 (en) * 2006-09-15 2008-03-19 Boehringer Ingelheim Pharma GmbH & Co. KG Methods of selecting cell clones
US20080268470A1 (en) * 2006-09-15 2008-10-30 Hitto Kaufmann Methods of selecting cell clones
EP2257620A1 (de) * 2008-03-19 2010-12-08 Boehringer Ingelheim Pharma GmbH & Co. KG Methode zur steigerung der reklonierungseffizienz
JP5304275B2 (ja) * 2009-01-29 2013-10-02 Jnc株式会社 アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
US8597943B2 (en) 2009-04-09 2013-12-03 Cellca Gmbh Method for improved single cell cloning
JP5697042B2 (ja) * 2009-11-19 2015-04-08 国立大学法人 岡山大学 遺伝子発現を上昇させるシステム及び該システムを保持したベクター
PE20141568A1 (es) 2011-10-28 2014-11-21 Neotope Biosciences Ltd Anticuerpos humanizados que reconocen la alfa-sinucleina
AU2013211874B2 (en) 2012-01-27 2017-11-02 Prothena Biosciences Limited Humanized antibodies that recognize alpha-synuclein
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
CU24446B1 (es) 2013-03-13 2019-10-04 Prothena Biosciences Ltd Un anticuerpo monoclonal humanizado que se une a tau
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
WO2015004632A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize iapp
US9951131B2 (en) 2013-07-12 2018-04-24 Prothena Biosciences Limited Antibodies that recognize IAPP
WO2015075635A2 (en) 2013-11-19 2015-05-28 Prothena Biosciences Limited Monitoring immunotherapy of lewy body disease from constipation symptoms
TW201623331A (zh) 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
US20170158755A1 (en) 2014-03-12 2017-06-08 Prothena Biosciences Limited Anti-laminin4 antibodies specific for lg1-3
WO2015136472A1 (en) 2014-03-12 2015-09-17 Prothena Biosciences Limited Anti-laminin4 antibodies specific for lg4-5
DK3116911T3 (da) 2014-03-12 2019-09-30 Prothena Biosciences Ltd Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
EP3129051A1 (en) 2014-04-08 2017-02-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
TWI786505B (zh) 2015-01-28 2022-12-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI718121B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI769570B (zh) 2015-01-28 2022-07-01 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
JP2018530540A (ja) 2015-09-16 2018-10-18 プロセナ バイオサイエンシーズ リミテッド 巨細胞動脈炎、リウマチ性多発筋痛症又は高安動脈炎の処置又は予防のための抗mcam抗体の使用
WO2017046774A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017149513A1 (en) 2016-03-03 2017-09-08 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2017153955A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
WO2017153953A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
BR112018072394A2 (pt) 2016-05-02 2019-02-19 Prothena Biosciences Limited anticorpos que reconhecem a tau
ES2933491T3 (es) 2016-05-02 2023-02-09 Prothena Biosciences Ltd Inmunoterapia tau
US10889638B2 (en) 2016-05-02 2021-01-12 Prothena Biosciences Limited Antibodies recognizing tau
WO2017208210A1 (en) 2016-06-03 2017-12-07 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2018007922A2 (en) 2016-07-02 2018-01-11 Prothena Biosciences Limited Anti-transthyretin antibodies
EP3478715A2 (en) 2016-07-02 2019-05-08 Prothena Biosciences Limited Anti-transthyretin antibodies
WO2018007924A2 (en) 2016-07-02 2018-01-11 Prothena Biosciences Limited Anti-transthyretin antibodies
US11958896B2 (en) 2017-05-02 2024-04-16 Prothena Biosciences Limited Antibodies recognizing tau
WO2019064053A1 (en) 2017-09-28 2019-04-04 Prothena Biosciences Limited DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES
EP3691626A4 (en) 2017-10-06 2021-06-30 Prothena Biosciences Limited METHODS OF DETECTION OF TRANSTHYRETINE
PH12020550694A1 (en) 2017-11-29 2021-04-12 Prothena Biosciences Ltd Lyophilized formulation of a monoclonal antibody against transthyretin
CN119409813A (zh) 2018-11-08 2025-02-11 普罗塞纳生物科学有限公司 识别tau的抗体
UA128431C2 (uk) 2018-11-26 2024-07-10 Форті Севен, Інк. ГУМАНІЗОВАНЕ АНТИТІЛО ДО c-Kit
PE20212324A1 (es) 2019-03-03 2021-12-14 Prothena Biosciences Ltd Anticuerpos que reconocen tau
US20230235048A1 (en) 2020-06-24 2023-07-27 Andriani IOANNOU Antibodies recognizing sortilin
AR133829A1 (es) 2023-09-15 2025-11-05 Othair Prothena Ltd Agentes penetrantes de células y usos de los mismos
TW202530253A (zh) 2023-09-15 2025-08-01 愛爾蘭商普羅希那生物科學有限公司 抗tdp-43抗體及其用途
AR133834A1 (es) 2023-09-15 2025-11-05 Prothena Biosciences Ltd Agentes de penetración célular y sus usos
WO2025059491A2 (en) 2023-09-15 2025-03-20 Prothena Platform Technologies Limited Methods, compositions, and kits including cell-penetrating agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US5008198A (en) 1984-09-14 1991-04-16 Scripps Clinic And Research Foundation Merozoite surface glycoproteins
EP0557459B1 (en) 1990-11-13 1997-10-22 Immunex Corporation Bifunctional selectable fusion genes
US5459058A (en) * 1991-03-28 1995-10-17 Benjamin Rich Cell culture system
CA2163427A1 (en) 1993-05-21 1994-12-08 Stephen D. Lupton Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
DE19539493A1 (de) 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
CN1299409A (zh) 1998-04-17 2001-06-13 雀巢制品公司 由正常人皮肤组织衍生的无限增殖细胞系
WO2000034326A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034325A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
EP1135532B1 (en) 1998-12-11 2011-03-16 Clontech Laboratories Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
JP2003504059A (ja) 1999-07-12 2003-02-04 ジェネンテック・インコーポレーテッド 発現ベクターと方法
AU780810B2 (en) * 1999-08-05 2005-04-21 Baxalta GmbH Recombinant stable cell clone, its production and use thereof
US7456017B2 (en) * 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
AU783767B2 (en) 1999-10-14 2005-12-01 Takara Bio Usa, Inc. Anthozoa derived chromophores/fluorophores and methods for using the same
JP2004510434A (ja) * 2000-10-03 2004-04-08 ユニバーシティ オブ ノース カロライナ 肝前駆細胞のクローン増殖方法
US20030073234A1 (en) * 2001-10-12 2003-04-17 Michal Amit Clonal human embryonic stem cell lines and methods of generating same

Similar Documents

Publication Publication Date Title
JP2007502608A5 (cg-RX-API-DMAC7.html)
JP6177260B2 (ja) 連続細胞培養で対象となるポリペプチドまたはウイルスを生成する方法
JP2010263903A (ja) 哺乳動物細胞中で分泌型組換えタンパク質を高生産させるための分子シャペロンの使用方法
WO2007015848A3 (en) Improved methods and compositions for increasing longevity and protein yield from a cell culture
CN109777773A (zh) 一种从造血干细胞分化产生nk细胞的方法及其培养基
Van der Velden-de Groot Microcarrier technology, present status and perspective
Lee et al. Red blood cell generation by three-dimensional aggregate cultivation of late erythroblasts
CN106414722A (zh) 红系细胞的体外扩增
Prentice et al. Improving performance of mammalian cells in fed‐batch processes through “bioreactor evolution”
CN106987559A (zh) 一种重组chok1细胞株的构建方法及其应用
JP2021512618A (ja) 閉鎖系におけるcar−t細胞の製造方法
CN116716348A (zh) 一种提高重组细胞的蛋白表达量的方法
CN103320406A (zh) 高活力谷胱甘肽过氧化物酶gpx1突变体及其制备方法
CN112899238B (zh) 基于RNA-m6A修饰水平的化合物筛选细胞模型及其构建与应用
JPH04228066A (ja) 外来遺伝子発現用培養細胞
Suarez-Patino et al. Transient expression of rabies virus glycoprotein (RVGP) in Drosophila melanogaster Schneider 2 (S2) cells
KR102648479B1 (ko) 단백질 기반 의약들 (protein-based pharmaceuticals) 의 고 수준 생산을 위한 세포주들 (cell lines)
CN116004645B (zh) 一种利用昆虫细胞生产人血清白蛋白的方法、核苷酸序列及表达载体
JP2859679B2 (ja) 新規細胞株
US20060252152A1 (en) Attachment of cells to surfaces
CN102199623A (zh) 蛋白质精氨酸甲基转移酶5的新用途
JP2006141356A (ja) Es細胞から樹立された造血幹細胞
Foster et al. Production of platelets in vitro in functionalized 3-dimensional scaffolds mimicking the bone marrow niche
Despars et al. Heterogeneity amongst splenic stromal cell lines which support dendritic cell hematopoiesis
Vatandoost et al. A study of recombinant factor IX in Drosophila insect S2 cell lines through transient gene expression technology